Main description:

In this book, Stefan Pieper supports doctors and therapists in easily diagnosing FQAD and in better and more adequately dealing with FQAD patients.
Fluoroquinolones, as one of the most common and effective groups of antibiotics, are known to have a distinct spectrum of side effects. These adverse effects are rare in percentage terms, but frequent in absolute numbers due to the enormous quantities of prescriptions. Because they are usually quite severe and wide-ranging, they tend to run like a syndrome and have been classified by the FDA as a separate condition, the FQAD, because of their frequency, severity and risk of disability.
This book presents for the first time a comprehensive description and classification of the clinical picture and a proposal for a clinical diagnostic tool based on diagnostic criteria.

Contents:

ForewordPreface1. Introduction to FQAD1.1 Bibliography2. FQAD and Oxidative Stress and Mitochondrial Toxicity2.1 Pathogenesis2.2 Diagnostics2.3 Therapy2.4 Bibliography3. FQAD and Musculoskeletal Damage / Collagen Disorder3.1 Pathogenesis3.2 Diagnostics3.3 Therapy3.4 Hydroxyproline3.5 Bibliography4. FQAD and Neurotoxicity / Peripheral Neuropathy (PN) / Autonomic Neuropathy / Small Fibre Neuropathy4.1 Pathogenesis4.2 Diagnostics4.3 Therapy4.4 Small Fibre Neuropathy4.5 Bibliography5. FQAD and Neuropsychiatric Adverse Effects5.1 Pathogenesis5.2 Diagnostics5.3 Therapy5.4 Bibliography6. Diagnostic criteria of the FQAD6.1. Preliminary considerations and requirements6.2 The FDA's diagnostic criteria6.3 The synoptic diagnostic criteria6.4 Diagnostic criteria with the cardinal symptoms for practice6.5 The Bell disability scale6.6 FQAD, acute and chronic form6.7 Bibliography7. Inside Story - Practical experience with FQAD Patients7.1 Epilogue7.2 Bibliography